Safety of the CIGB-300 application associated to diphenhydramine pre-medication in the epidermoid carcinoma of the uterine neck stage Ib2-II. Phase I study.
Latest Information Update: 14 Oct 2020
Price :
$35 *
At a glance
- Drugs CIGB 300 (Primary) ; Cisplatin; Diphenhydramine
- Indications Carcinoma; Cervical cancer
- Focus Adverse reactions
- Acronyms CERVISEG-II
- 10 Jun 2013 New trial record